Show simple item record

dc.creatorGillis, Justinen
dc.date.accessioned2011-07-12T18:21:17Zen
dc.date.available2011-07-12T18:21:17Zen
dc.date.created1999-09-27en
dc.date.issued1999-09-27en
dc.identifierhttp://www.washingtonpost.comen
dc.identifier.bibliographicCitationWashington Post Business 1999 September 27; p. 18-20en
dc.identifier.urihttp://hdl.handle.net/10822/512345en
dc.formatNews Articleen
dc.languageengen
dc.source207713en
dc.subjectGenomicsen
dc.subjectResearchen
dc.subject.classificationGenome Mappingen
dc.subject.classificationBusiness Ethicsen
dc.titleCracking the Code: A Bold Business Experiment Is Unfolding at Celera Genomics, Where Scientists Face a Herculean Task: Unravel the 3.5 Billion Letters of the Human Genetic Code. The Big Question for Investors: Can the Maryland Biotech Company Earn a Profit on Its Research?en
dc.provenanceDigital citation created by the Bioethics Research Library, Georgetown University, for the National Information Resource on Ethics and Human Genetics, a project funded by the United States National Human Genome Research Instituteen
dc.provenanceDigital citation migrated from OpenText Livelink Discovery Server database named GenETHX to DSpace collection GenETHX hosted by Georgetown Universityen


This item appears in the following Collection(s)

Show simple item record


Georgetown University Seal
©2009—2019 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885